<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for NPSP</title>
    <link />
    <description>Headlines for NPS Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst &amp;</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/nps-pharmaceuticals-president-and-ceo-dr-francois-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 08:41:28 GMT</pubDate>
    </item>
    <item>
      <title>NPS Pharmaceuticals Recognized by National Organization for Rare Disorders for Gattex® as an Innovat</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/nps-pharmaceuticals-recognized-by-national-organiz/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 09:05:46 GMT</pubDate>
    </item>
    <item>
      <title>NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99314/nps-pharma-incurs-narrower-1q-loss.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 14 May 2013 09:23:01 GMT</pubDate>
    </item>
    <item>
      <title>NPS Pharmaceuticals Inc Stock Upgraded (NPSP)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11922177/1/nps-pharmaceuticals-inc-stock-upgraded-npsp.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 14 May 2013 05:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Why NPS Pharmaceuticals Is Up After Earnings</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/why-nps-pharmaceuticals-is-up-after-earnings/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 15:12:00 GMT</pubDate>
    </item>
    <item>
      <title>NPS Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1419871-nps-pharmaceuticals-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 14:25:06 GMT</pubDate>
    </item>
    <item>
      <title>NPS Pharmaceuticals Reports First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/nps-pharmaceuticals-reports-first-quarter-2013-fin/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 08:43:34 GMT</pubDate>
    </item>
    <item>
      <title>NPS Pharmaceuticals to Report First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/nps-pharmaceuticals-to-report-first-quarter-2013-f/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 08:44:58 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Oppenheimer Initiates NPS Pharmaceuticals with Outperform on Leading Assets</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/04/3524339/update-oppenheimer-initiates-nps-pharmaceuticals-with-ou.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 24 Apr 2013 08:58:01 GMT</pubDate>
    </item>
    <item>
      <title>2 Pharmaceutical Buys Under $15 With Strong Catalysts</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1351621-2-pharmaceutical-buys-under-15-with-strong-catalysts.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 13:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CFO Sells Highlight: KO, KKD, PIR, NPSP, ACAD</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/216588/weekly-cfo-sells-highlight-ko-kkd-pir-npsp-acad.aspx?source=itxwebtxt0000015</link>
      <author>GuruFocus</author>
      <pubDate>Tue, 16 Apr 2013 12:31:09 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CFO Sells Highlight: KO, KKD, PIR, NPSP, ACAD</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/weekly-cfo-sells-highlight-ko-kkd-pir-npsp-acad-cm237295.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 16 Apr 2013 12:07:30 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Mad Money - Is Apple Bottoming? (4/2/13)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1316681-cramer-s-mad-money-is-apple-bottoming-4-2-13.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 03 Apr 2013 06:37:05 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: WM VRTX SRPT NPSP DR</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11885406/1/cramers-top-stock-picks-wm-vrtx-srpt-npsp-dr.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 03 Apr 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Stock Picks From 'The Next David Einhorn'</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1312871-3-stock-picks-from-the-next-david-einhorn.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 01 Apr 2013 16:27:10 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/23/this-week-in-biotech-20/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 23 Mar 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>1 of These 3 Stocks Won't Hold Its Gains</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/one-of-these-3-stocks-wont-hold-its-gains/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 19:06:19 GMT</pubDate>
    </item>
    <item>
      <title>Orphan Drug Is Headed Back to Its Parent</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/orphan-drug-is-headed-back-to-its-parent/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 14:40:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Wedbush Raises PT on NPS Pharmaceuticals on Rights Buyback</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3432581/update-wedbush-raises-pt-on-nps-pharmaceuticals-on-right.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Mar 2013 10:41:06 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Raises PT on NPS Pharmaceuticals on Regained Product Rights</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3432010/update-jefferies-raises-pt-on-nps-pharmaceuticals-on-reg.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Mar 2013 08:59:12 GMT</pubDate>
    </item>
  </channel>
</rss>
